TABOURET Emeline
Onglets principaux
Publications
http://api.archives-ouvertes.fr/search/?&fq=authLastNameFirstName_s:%28%22Tabouret+Emeline%22%29&fl=title_s,en_title_s,docid,label_s,en_label_s,authIdHal_s,halId_s,structId_i,uri_s,keyword_s,en_keyword_s,authLastNameFirstName_s,journalTitle_s,abstract_s,en_abstract_s,producedDate_tdate,producedDateY_i,language_s&sort=publicationDate_s+desc
-
Peptide radionuclide radiation therapy with Lutathera in multirecurrent nonanaplastic meningiomas: antitumoral activity study by growth rate analysisJournal of Neuro-Oncology2024
-
Prognostic value of Beta 2-Microglobulinin in cerebrospinal fluid in primary central nervous system lymphoma.Journal of the Neurological Sciences2024
-
Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergismsEBioMedicine2023
-
Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergismsEBioMedicine2023
-
Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419)European Journal of Cancer2023
-
TP5: A Novel Therapeutic Approach Targeting Aberrant and Hyperactive CDK5/p25 for the Treatment of Colorectal CarcinomaInternational Journal of Molecular Sciences2023
-
Deciphering the Action of Neuraminidase in Glioblastoma ModelsInternational Journal of Molecular Sciences2023
-
Radio-chemotherapy feasibility for biopsy-only unresectable IDH wild-type glioblastomas (BO-GBM)Neuro-Oncology Practice2023
-
SARS-CoV-2 infection in patients with primary central nervous system lymphoma in the vaccination eraLeukemia & lymphoma2023
-
Plasma nanoDSF Denaturation Profile at Baseline Is Predictive of Glioblastoma EGFR StatusCancers2023
-
Challenges in glioblastoma research: focus on the tumor microenvironmentTrends in Cancer2023
-
Editorial: Novel diagnostic and therapeutic strategies in the management of cerebral gliomasFrontiers in Oncology2023
-
SARS-CoV-2 infection in patients with primary central nervous system lymphoma in the vaccination eraLeukemia & lymphoma2023
-
Primary central nervous system lymphoma (PCNSL) in older patientsCurrent Opinion in Oncology2023
-
Innovative treatments for meningiomasRevue Neurologique2023
-
Soluble CD146, a biomarker and a target for preventing resistance to anti-angiogenic therapy in glioblastomaActa Neuropathologica Communications2022
-
Characteristics, Patterns of Care and Predictive Geriatric Factors in Elderly Patients Treated for High-Grade IDH-Mutant Gliomas: A French POLA Network StudyCancers2022
-
Prognostic value of circulating lymphocyte subsets in primary central nervous system lymphomaJournal of Neuro-Oncology2022
-
Diagnosis and Treatment of Pineal Region Tumors in Adults: A EURACAN OverviewCancers2022
-
Genomic analysis of paired IDHwt glioblastomas reveals recurrent alterations of MPDZ at relapse after radiotherapy and chemotherapyJournal of the Neurological Sciences2022
-
Clinical Impact of High Throughput Sequencing on Liquid Biopsy in Advanced Solid CancerCurrent Oncology2022
-
Adult H3K27M mutated thalamic glioma patients display a better prognosis than unmutated patientsJournal of Neuro-Oncology2022
-
Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary studyActa Neuropathologica Communications2022
-
Predictive geriatric factors in elderly patients treated for idh-mutant high-grade gliomas: a French Pola network studyNeuro-Oncology2021
-
Le Conseil national des universités en cancérologie-radiothérapie : actualisation des critères de sélection présentés aux lecteurs du Bulletin du CancerBulletin du Cancer2021
-
Association of inoperable glioblastoma with a heterogeneous functional and survival outcome.Journal of Clinical Oncology2021
-
Olaparib in recurrent IDH-mutant high-grade glioma (OLAGLI).Journal of Clinical Oncology2021
-
Predictive value of lymphocyte immunophenotyping (LIP) in primary central nervous system lymphoma (PCNSL).Journal of Clinical Oncology2021
-
Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adultsNeuro-Oncology Advances2021
-
TEMOBIC : Phase II Trial of Neoadjuvant Chemotherapy for Unresectable Anaplastic Gliomas: An ANOCEF StudyOncologist2021
